Koyfin Home > Directory > Health Care > Amicus Therapeutics > Enterprise Value

Amicus Therapeutics Enterprise Value Chart (FOLD)

Amicus Therapeutics annual/quarterly Enterprise Value from 2007 to 2018.
  • Amicus Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $2,617m a 49.70% increase of 1,301m year over year
  • Amicus Therapeutics Annual Enterprise Value for 2017 was $2,143m a 73.82% increase of 1,582m from 2016
  • Amicus Therapeutics Annual Enterprise Value for 2016 was $561m a -82.72% decrease of -464m from 2015
  • Amicus Therapeutics Annual Enterprise Value for 2015 was $1,025m a 31.34% increase of 321m from 2014
Other Valuation Metrics:
  • Amicus Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,811m a 48.80% increase of 1,372m year over year
  • Amicus Therapeutics Price / Book for the quarter ending March 03, 2018 was 7.12 a 34.98% increase of 2.49 year over year
View Chart On Koyfin

Quarterly FOLD Enterprise Value Data

03/2018$2,617m
12/2017$2,143m
09/2017$2,414m
06/2017$1,316m
03/2017$842m
12/2016$561m
09/2016$903m
06/2016$566m
03/2016$886m
12/2015$1,025m

Annual FOLD Enterprise Value Data

2017$2,143m
2016$561m
2015$1,025m
2014$704m
2013$91m
2012$27m
2011$51m
2010$75m
2009$5m
2008$45m